Bone Biologics Corporation (BBLG) vs IM Cannabis Corp. (IMCC)

A side-by-side comparison of Bone Biologics Corporation and IM Cannabis Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BBLG

Bone Biologics Corporation

$873327

$0.48HealthcareDelayed quote: Oct 6, 2026, 11:56 AM EDT

IMCC

IM Cannabis Corp.

$1M

$1.89HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT

Total return — BBLG vs IMCC

growth of $100 · dividends reinvested · last 5y

BBLG -100.0% (-82.9%/yr)IMCC -100.0% (-80.0%/yr)IMCC compounded faster over this window

BBLG IMCC

BBLG vs IMCC: by the numbers

•IMCC is the larger company ($1M vs $873327 market cap).
•Both run net losses; BBLG's is the smaller (0.00% vs -38.08% net margin).

Metrics side by side

Valuation

Metric	BBLG	IMCC
P/S ratio	N/A	0.04
P/B ratio	0.22	N/A

Profitability

Metric	BBLG	IMCC
Gross margin	0.00%	13.74%
Operating margin	0.00%	-25.95%
Net margin	0.00%	-38.08%
ROE	-73.66%	N/A
ROIC	-78.01%	-128.95%

Growth (annualized)

Metric	BBLG	IMCC
Revenue CAGR (5Y)	N/A	4.19%
Total return CAGR (5Y)	N/A	-80.08%

Go deeper

Full BBLG analysis Full IMCC analysis Interactive comparison tool

Dig into the metrics

Bone Biologics ROE IM Cannabis ROE Bone Biologics operating margin IM Cannabis operating margin Bone Biologics revenue growth IM Cannabis revenue growth Bone Biologics free cash flow IM Cannabis free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.